Perrigo | PRGO - Assets


Perrigo reported $7.48B in Assets for its fiscal quarter ending in September of 2026.





Assets Change Date
AbbVie USD 147.68B 12.57B Sep/2026
Abbott USD 108.25B 968M Sep/2026
Bayer EUR 113.47B 6.18B Sep/2026
Bristol-Myers Squibb USD 88.77B 1.14B Sep/2026
Coherus Biosciences USD 191.18M 74.84M Jun/2026
Corcept Therapeutics USD 1.03B 145.32M Sep/2026
Dr.Reddys Laboratories INR 576.31B 1.01B Sep/2026
Eli Lilly USD 148.07B 5.79B Sep/2026
J&J USD 197.42B 3.64B Sep/2026
Merck USD 132.77B 2.97B Sep/2026
Nestle CHF 128.38B 1.23B Jun/2026
Pacira USD 34.68B 33.44B Sep/2026
Perrigo USD 7.48B 124.6M Sep/2026
Pfizer USD 204.54B 3.41B Sep/2026
Phibro Animal Health USD 1.51B 13.48M Sep/2026
Prestige Brands USD 4.72B 153.09M Sep/2026
Reckitt Benckiser GBP 25.3B 1.11B Dec/2024
Sanofi EUR 130.29B 1.23B Sep/2026
Supernus Pharmaceuticals USD 1.4B 30.42M Sep/2026
Teva Pharmaceutical Industries USD 40.04B 185M Sep/2026
Xeris Pharmaceuticals USD 423.22M 11.31M Sep/2026
Zoetis USD 15.09B 11M Sep/2026